REVIEW ON IMMEDIATE RELEASE DOSAGE FORM by S.G.Gavande, R.O.Sonwane, A.D.Pichkewar, S.S.Dorik.
IAJPS 2019, 06 (04), 8509-8518                     S.G.Gavande et al                       ISSN 2349-7750 
 
 
 
w w w . i a j p s . c o m  
 
Page 8509 
 
        CODEN [USA]: IAJPBB                        ISSN: 2349-7750 
 
  INDO AMERICAN JOURNAL OF 
 PHARMACEUTICAL SCIENCES 
                              
Available online at: http://www.iajps.com                                     Review Article 
REVIEW ON IMMEDIATE RELEASE DOSAGE FORM 
1S.G.Gavande, 2R.O.Sonwane, 3A.D.Pichkewar, 4S.S.Dorik. 
1R.C.Patel Institute of Pharmaceutical Education And Research, Shirpur. Dist-Dhule 425405 
Email Id-raju-sonwane1979@redifmail.com, Contact No: 9158066822, 9421521905. 
Article Received: February 2019        Accepted: March 2019           Published: April 2019 
Abstract:  
Most popular immediate release dosage forms such as tablet, capsule and pellet. Because of its convenience of self-
administration, and simple to the manufacturing. The type of dosage from is some advantages such as improved 
stability of formulation. Improved bioavablity of Product. Rapid onset action and cost effective as compare to other 
dosage formulation. They disintegrant are selected as type of dosage and physical characteristics of drugs. The 
basic approach used in development tablets, capsule and pellet as the use of some excipient like superdisintegrants, 
Bulking agent, Emulsifying agent, Binders, Lubricants, Flavouring and Sweetening agent As a drug entity nears the 
end of its patent life, it is common for pharmaceutical manufacturers to develop a given drug entity in a latest and 
improved dosage form. 
The manufacturing of Immediate release tablet, capsule and pellet they using various method such as, Tablet 
Modling, Wet Granulation, Direct Compression, Solid Dispersion. capsule Direct filling, wet Granulation, and 
pellets Extrusion, Sphronization, Globulation, Spray Drying, Spray congealing, Compression. 
Key Words:- Immediate Release, Superdisintigrent, Conventional Techniques. 
Corresponding author:  
S.G.Gavande, 
R.C.Patel Institute of Pharmaceutical Education And Research,  
Shirpur. Dist-Dhule 425405, Email Id-raju-sonwane1979@redifmail.com,  
Contact No: 9158066822, 9421521905. 
 
 
Please cite this article in press S.G.Gavande et al., Review On Immediate Release Dosage Form., Indo Am. J. P. 
Sci, 2019; 06(04). 
 
 
QR code 
 
 
IAJPS 2019, 06 (04), 8509-8518                     S.G.Gavande et al                       ISSN 2349-7750 
 
 w w w . i a j p s . c o m  
 
Page 8510 
INTRODUCTION: 
Oral Solid Dosage: 
The country of India with an increase in population, 
and the demand for health care services is an also 
increasing. With change in lifestyles and so-called  
“fast culture”. The good health is almost important 
part.  The change of the life style the disease is also 
changed. The ultimate goal of any drug delivery 
system is effective disease management and 
minimum side effects and greater patient compliance 
in a cost effective manner. The drug therapeutic index 
could be large while index of difficult reactions or 
side effects could be minimum by regulating the drug 
release in human body in a well-defined restricted 
manner. This would remove the haphazard and 
unrestrained blood plasma profiles of drugs usually 
associated with conventional dosage forms. Tablets, 
capsule and pellets are solid dosage form that is 
compacted into small, formed oval, round shapes. 
This formulation is use in the mouth for oral 
administration. They consist of several components. 
These components help to the formulation is properly 
digested in the body, is easy to swallow, and change 
the taste, and controls the timed release of the drug to 
produce the desired effect. Solid oral delivery 
systems the system of choice of all drug delivery 
system and they do not require special treatment.  
Based on their drug-release characteristics. (1,2) 
The Immediate release formulation  are those which 
disintegrate quickly and get dissolved to release the 
dosage’ of immediate release may be provided for by 
way of an  suitable pharmaceutically adequate 
diluents, which diluents  does not delay, to an 
considerable extent, the rate of drug release and/or 
absorption. The FDA defined fast dissolving 
formulation as “a solid dosage form containing 
therapeutic substance it which disintegrate quickly 
usually within a subject of seconds when placed on 
the tongue. 
 
Advantages of Immediate Release Drug Delivery 
System (10, 11, 21) 
1. Improved stability. 
2. Improved bioavability of product 
2. Improved patient compliance. 
3. Rapid onset of action. 
4. Suitable for controlled/sustained release dosage 
form. 
5. Allows large drug loading. 
6. Adaptable and agreeable to active processing and 
packaging machinery. 
7. Cost is minimum as compare to other dosage 
formulation. 
Disadvantage 
1. Frequent dose is necessary for drug with short half 
life. 
2. Drug release at a time may produce high plasma 
concentration which may produce toxicity. 
Ideal Characteristics of Drug In Immediate 
Release Dosage Form ( 3,6,10) 
Immediate release dosage formulation should In the 
case of solid dose it dissolves in the stomach within a 
little time period. 
1. In the case of liquid dosage formulation they 
should be compatible with taste masking. 
2. It should not leave minimum or no residue present 
in the mouth after fill oral administration. 
3. Display minimum sensitivity to environmental 
condition as humidity and temperature. 
4.Have a placing mouth feel. 
 
The Drug used in Immediate Release formulation used drug and Their Functional Category:  (1,3,7) 
Functional 
Category 
Drug Used in immediate Release Formulation 
Analgesics and Anti 
-inflammatory  
Agents 
Azapropazone, Auronafin, Diflunisal, Fenoprofen Calcium, Fenaben, Ibuprofen, Indomethacin, 
Ketoprofen, Meclofenamic Acid, Mefenamicacid, Nabumetone, Oxyphenbutazone. 
Anthelmintics Albendazole, Dichlorophen Mebendazole, Oxantel, Oxamniquine Oxfendazol Embonate, 
Embonate, Thiabendazole. 
 
Anti-Arrhythmic 
Agents 
Amiodarone Hcl, Disopyramide, Flecainide Acetate. 
 
Anti-bacterial Agents 
 
Benethamine Penicillin, Penicillin, Ciprofloxacin HCl, Clarithromycin, Clofazimine, Cinoxacin, 
Doxycycline, Erythromycin, Nalidixic Acid, Nitrofurantoin, Rifampicin, Sulphamethoxazole, 
Sulphapyridine, Sulphabenzamide, Trimethoprim. 
 
Anti-coagulants 
 
Dicoumarol, Dipyridamole 
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OTHER EXCIPIENTS   (3,4,5,6,10) 
Excipients are the properties of balance the active 
ingredients in use immediate release dosage forms. 
The need thorough belief of the chemistry of these 
ingredients to avoid interaction. Determining the cost 
of these ingredients is another issue that needs to be 
addressed by formulators. The part and purpose of 
excipients is main formulation of immediate 
dissolving tablets. They are unmoving foodstuff 
grade recipients, when incorporated in the 
formulation; impart the required organoleptic 
properties and product efficacy. Ingredients are local 
and can be used for a large range of activities, except 
some activities that require taste masking agents. 
 
  
Anti-depressants 
 
Amoxapine, Ciclazindol, Maprotiline HCl,Mianserin HCl,Trazodone HCl 
Anti-diabetics 
 
Acetohexamide, Chlorpropamide,Glibenclamide,Gliclazide, Glipizide 
 
Anti-gout Agents Allopurinol,Sulphinpyrazone, Probenecid. 
 
Anti-hypertensive 
Agents 
Amlodipine, Carvedilol, Benidipine, Darodipine,Dilitazem Hcl,Diaxoide  Dilitazem, Gunabenz 
Acetate, Isiradipine, Indoramin, Niciradipine, Nifedipine, Nimodipine, Reseripine. 
Anti-migraine 
Agents: 
 
Dihydroergotamine Mesylate, Succinate  methyseragide maleate, Sumatriptan succinate pizotrfen 
maleate. 
Anti-muscarinic 
Agents: 
 
Atropine, Benzhexol Hcl, Biperiden, EthopropazineHcl, butyl bromide,mepenzolate bromide, 
oxyphenacycimine HCL, Tropicamide, biperiden. 
 
Anti-
neoplasticAgents and 
Immunosuppressants 
 
Amsacrine,Aminoglutethimide, Azathioprne, Chlorambucil, Cyclosporin, Dacarbazine, 
Etoposide, Estramutine, Lomustine, Mercptopurine, Metomycin,Mitozantrone,Methotrexate, 
Procarbazine Hcl, Testolactone,Tamoxifen Citrate. 
 
Anti-protazoal 
Agents 
 
Benznidazole, Diloxanide Furoate, Decoquinate, Diiodohydroxyqunilone, Metronidazole, 
Nimorazole, Nitrofurazone,Omidazole, Tinidazole. 
 
Anti-thyroid Agents Carbimazole, propylthiouracil. 
 
Anxiolytic, 
Sedatives, Hypnotics 
and Neuroleptics 
 
Alprazolam, Amylobarbitone,Bentazepam, Bromoperidol, Barbitone, Brotzolm , Carbromal, 
Chlormethazole, Chlordiazepoxide, Clobazam, Clotiazepam,Clozapine, Flunitrazepam, 
Flunanisone, Fluopromazine Decanoate, Fluarzepam, Haloperidol. 
 
Anti-fungal Agents 
 
Amphotericin, Butoconazolenitrate, Clotrimazole, Econazolenitrate 
,Grisiofulvin,Nysatatin,Nitreate,Ketoconazole,Terconazolae,       Tioconazole,Terbinafine Hcl. 
Cardiac Inotropic 
Agents 
Amrinone,  Digoxin,Digititoxin,Lanatoside C,Enoximine, Medigoxin. 
Corticosteroids 
 
Beclomethasone, Betamethasone, Budesonide, Cortisone Acetate, Desoxymethasone, 
Methylprednisolone, Prednisone, Prednisolone, Triamcinolone. 
 
Diuretics 
 
Acetazolamideamiloride, bendrofluazide, bumetanide, chlorthalidone, 
chlorothiazide,frusemide,metolazone,Spirolactone,ehacrynicacid,trimeterence. 
Enzymes 
 
All Enzymes. 
Gastro-intestinal 
Agents 
 
Bisacodyl, cimetidine, cisapride, diphenoxylate Hcl, loperamide, famotidine,mesalazine, 
omeprazole, ondansertron Hcl, nizatidine. 
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Fig.1:- Ingredient used in different Immedeate dosage formulation. 
 
Bulking Materials: 
Bulking ingredients are significant in the formulation 
of Immediate release formulation. The substance 
contributes functions of a filler, diluents and price 
reducer. Bulking agents are add in the range of 10 
percent to about the 90 percent by weight of the final 
composition .Ex. mannitol, polydextrose, lacitalol, 
starch hydrolysate. 
 
Emulsifying Agents: 
Emulsifying agents are important ingredient for 
manufacturing of immediate release formulation they 
help in quick drug release and disintegration. These 
agents can be included in the range between the 0.05 
percent to about 15 percent of the weight by final 
composition. Ex.  propylene glycol esters, lecithin, 
sucrose esters, and others. 
 
Lubricants: 
Lubricants, are not essential ingredient, can more 
assist in manufacture these formulations more edible 
after the disintegrate to the mouth. Lubricants are 
removed the grittiness and   drug transfer mechanism 
from the mouth to the stomach.eg. Magnesium state, 
Talc, Boric acid, Steric acid. 
 
Flavours and Sweeteners: 
Flavors and taste-masking ingredients make the 
products are more palatable and pleasant of the 
patients. The addition of some flavoring ingredients 
to assists in overcome bitterness and undesirable 
tastes of some formulation.  Ex. Sugar, fructose and 
dextrose, as well as non- nutritive sweeteners   as also 
used such as sodium saccharin, sugar alcohols and 
sucrluose. 
 
Super Disintegrant: A disintegrant is a substance, 
which is fill up to a tablet or capsule blend to aid in 
the breakup of the compressed mass when it is place 
into a fluid of the surroundings. They increase 
moisture of the tablet. Superdisintegrants are used at 
a little amount in the solid dosage foam, typically 1-
10 % by weight relative to the total weight of the 
dosage unit. 
Superdisintegrants are contact with water the tablet, 
capsules or pellets are swell and hydrate they modify 
volume in the tablet, capsule or pellet. Effective 
superdisintegrants provide improve compressibility, 
Compatibility and have no harmful impact on the 
mechanical strength of formulations containing large-
dose of drugs. eg. Sodium starch glycolate, 
Polyvinylpyrrolidone, Calcium Silicate. ( 2,5,10,21) 
 
Advantages:  
 1. Effective in low concentrations  
 2. Minimum effect on compressibility. 
3. More effective in itragranularly. 
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Some Common Super disintegrate are used as Tablet, Capsule, and Pellet Formulation: (23) 
 
Name Of Super Disintegrant  Mechanism of Action. 
Sodium Starch Glycolate (Explotab, Primogel) Rapid and extensive swelling with nominal gelling. 
Microcrystalline cellulose used in concentration of 2-15% of 
tablet weight. And Water wicking. 
Cross-linked Providone (Killiodone) Water wicking, swelling and probably some deformation 
recovery. Fastly disperses and swells in water, but does not gel 
even after prolonged exposure. Greatest rate of swelling 
compared to other disintegrant. Greater surface area to volume 
ratio than other disintegrants .Used in concentration 2-5% of 
weight of tablet. 
Low substituted Hydroxy propyl cellulose  
This is insoluble in water. Fastly swells in water. Grades LH-11 
and LH-21 exhibit the greatest degree of swelling. Certain 
grades can also provide some binding properties while retaining 
disintegration capacity. Recommended concentration 1-5%  
 
Cross linked carboxy methyl cellulose Wicking due to fibrous structure, swelling with minimal 
gelling. Effective Concentrations: 1-3% Direct Compression, 2-
4% Wet Granulation 
Cross linked  cellulose Swells 4-8 folds in < 10 seconds. Swelling and wicking both. 
Calcium silicate Wicking action. 
 
 
Conventional Techniques used in The Preparation of Immediate Release formulation: 
 
 
Fig.2:- Formulation of dosage from preparation Method And Evaluation Parameter. 
 
  
1. Tablet Moulding Technique: (4,) 
These methods, used in water-soluble ingredients that 
tablet disintegrate and dissolve rapidly. 
The powder mixture is moistened with a hydro 
alcoholic solvent and is moulded in to tablet using 
compression pressure lower than used in 
conventional tablets compression. The solvent is the 
separate by air-drying. Moulded tablets have a leaky 
structure that improved dissolution.  They two 
problems normally found are mechanical strength and 
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reduced taste masking characteristics of tablet, 
capsule or pellets. Using binding of the agents such 
as sucrose, acacia or poly vinyl pyrrolidone can 
improved the mechanical force of the tablet. 
To overbear reduced taste masking characteristic Van 
Scoik incorporated drug containing discrete particles, 
which were formed by spray congealing a molten 
mixture of hydrogenated cottonseed oil, sodium 
bicarbonate, lecithin, polyethylene glycol and active 
excipients into a lactose based tablet triturate form. 
 
2. Wet granulation 
Wet granulation is a process of used in a small 
amount of liquid binder to lightly agglomerate the 
powder blend. 
The amount of liquefy the substance has to be the 
controlled, as over-wetting will cause the granule to 
be rigid and under-wetting will cause them to be soft 
and spindly. 
i. The active substances and excipients are checked, 
weighed and mixed the properly. 
ii. The wet granulation is prepared by adding the 
liquid binding agent–adhesive to the powder blend 
and mixing thoroughly.  
iii. Screening the damp mass through a mesh to form 
the granules. 
iv. Dry granules is a conventional fluid-bed dryer are 
most commonly used. 
Limitation of wet granulation 
The great disadvantage of wet granulation is it’s a 
minimize the cost or cost effective. It is a large 
process because of labour, equipment, time, energy 
and time requirements for preparation of granules. 
1. Loss of material during various types of processing 
to preparation of granules. 
2. Stability may be a main issue for dryness sensitive 
or thermo labile drug. 
 
3. Direct Compression (4,5)  
The name direct compression is used to define the 
method by which tablets are compacted to direct 
from of powder material of the active substance and 
appropriate excipients which will uniform flow of 
powder in die cavity and form this powder substance 
are compacted. 
 
Advantages 
1.Direct compression  technique is more capable and 
cheap process as compared to wet granulation, 
molding, mass extrusion techniques because it 
involves only dry blending and compression of tablet 
used  of API and necessary excipients. 
2. The most popular advantage of direct compression 
is that it is an cheap process. Reduced time, Reduced 
cost of labour, fewer manufacturing steps, and 
minimum number of equipment’s are required, less 
process validation, reduced use of energy. 
3. Uniformity of particle size. 
 
4. Solid dispersions technique 
The formulation of solid amorphous dispersions into 
fast release solid dosage formulation for oral 
administration through GI tract of an animal and 
human, it is frequently desirable to maximum 
quantity of dispersion present in the dosage 
formulation. This low volume of the solid dosage 
form required to complete the desired dose. Such 
large drug loadings of dispersion in a solid dosage 
form reduce the dosage formulation volume, making 
it easier for the patient to swallow it and cure to 
advance patient compliance. 
 
The minimum quantity, the dispersions used in the 
current device present concentration and development 
of relative control consist of crystalline drug is alone. 
Thus, the concentration is increasing  polymer is 
present in a suitable quantity so that the dispersion is 
administered to the use of environment, then 
dispersion provides improved drug concentration 
relative to a control consisting of an the same amount 
of crystalline drug, but with no concentration-
increasing  polymer present. 
 
The immediate release dosage formulation  
containing a solid dispersion that enhances the 
solubility of  “minimum-solubility drug,” meaning 
that the drug may be either “mostly water-insoluble,” 
which means that the drug has a minimum  aqueous 
solubility at physiologically relevant pH (e.g., pH 1-
8) of less than 0.01 mg/mL, “sparingly water-
soluble,” that is, has an aqueous solubility up to about 
1 to 2 mg/mL, or even minimum to moderate  
aqueous-solubility, having an aqueous-solubility 
from about 1 mg/mL to as high as about 20 to 40 
mg/mL. 
 
5. Mass-Extrusion (5) 
Here become softer of active mixture is  done with 
solvent mixture of water-soluble methanol and 
polyethylene glycol as  subsequent elimination of 
softened mass through the syringe to get a cylinder of 
the substance into flat segments using the heated 
cutting edge to form tablets. In case of bitter drug 
granules can be coated with the help of dried cylinder 
to achieve taste masking. 
 
6. Extrusion: (22) 
Prepared wet mass was immediately extruded 
through sieve number 14 (B. S. S.) to get compact 
cylindrical extrudates of uniform diameter. 
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7. Spheronization: (22) 
The extrudates were spheronised using lab 
Spheronizer (Shakti Pharmatech) at 800 rpm with 5 
mm friction plate to get spherical pellets. Wet pellets 
were dried in Fluid Bed Dryer (FBD) for 10 min 
keeping product temperature below 65 °C. 
 
Preformulation Study of Immedeate Release 
Dosage Form:-  
A) Evaluation of Blend: (4,13,) 
1.  Angle of repose 
2. Tapped density 
3. Bulk density 
4. Carr’s index 
5. Hauser’s ratio 
 
1. Angle of Repose: 
Angle of repose of Active Pharmaceutical Ingredients 
the bleach was resolute by the use of funnel method. 
The correctly weigh of bleach mixture was placed in 
the funnel. The height of the funnel adjusted in such a 
way that the tip of the funnel now touches the top of 
the powder mixture. The bleach mixture was the 
certified and flow through the funnel freely on to the 
surface. The width of the bleach cone was calculated 
and angle of repose was calculated using the 
following equation.   
𝑨𝒏𝒈𝒍𝒆 𝒐𝒇 𝒓𝒆𝒑𝒐𝒔𝒆=𝑻𝒂𝒏−(Height of cone/ Radius 
of disc)  
 
2. Tapped density: 
Tapped density is achieved by automatically tapping 
of measuring cylinder containing the bleach sample. 
Correctly 25 g of drug was weighed, which was 
previously passed through 20 # mesh and transferred 
in 100 ml graduated cylinder. Then the cylinder 
contain to the sample was automatically tapped by 
raising the cylinder and allowing it to drop under its 
own weight using the automatically tapped density 
tester. After observe the original volume, the tube is 
automatically tapped and volume reading is taken 
until little further volume changes are the observed. 
The automatic tapping is achieve by raising the tube 
and allow it to fall under its own weight of a definite 
distance. Instruments that rotate the tube during 
tapping may be preferred to decrease any achievable 
separation of the mass during tapping down. Tapped 
density is the calculated in gm / ml. (Martin et al 
2001).  
The tapped density was calculated by using the 
following formula  
 
                                     𝑻𝒂𝒑𝒑𝒆𝒅 𝑫𝒆𝒏𝒔𝒊𝒕𝒚 =
𝐖𝐞𝐢𝐠𝐡𝐭 𝐨𝐟 𝐩𝐨𝐰𝐝𝐞𝐫 𝐢𝐧 𝐠𝐦
𝐓𝐚𝐩𝐩𝐞𝐝 𝐯𝐨𝐥𝐮𝐦𝐞 𝐢𝐧 𝐛𝐥𝐞𝐧𝐝 𝐢𝐧 𝐜𝐦
 
 
3. Bulk Density:  
The bulk density is described as weight per unit 
volume. Bulk density is defined as the mass of the 
bleach divided by the bulk volume and is expressed 
as gm / cm3. Correctly of drug was weighed, which 
was before passed through mesh and transfer in 100 
ml graduated cylinder. Carefully level the bleach 
without compacting, and read the disturbed apparent 
volume (V0). The bulk density was calculated by 
using the following formula           
                                                                                                        
𝑩𝒖𝒍𝒌 𝑫𝒆𝒏𝒔𝒊𝒕𝒚 =
𝐖𝐞𝐢𝐠𝐡𝐭 𝐨𝐟 𝐏𝐨𝐰𝐝𝐞𝐫
𝐁𝐮𝐥𝐤 𝐕𝐨𝐥𝐮𝐦𝐞
 
 
 
4. Compressibility Index: 
The simple way for measurement of free flow of 
bleach is compressibility, an warning of the ease with 
which a material can be induced to flow is given by 
compressibility index (I) calculated as follows 
 
                                                         
% 𝑪𝒐𝒎𝒑𝒓𝒆𝒔𝒔𝒊𝒃𝒊𝒍𝒊𝒕𝒚 =
𝐔𝐧𝐭𝐫𝐚𝐩𝐩𝐞𝐝 𝐕𝐨𝐥𝐮𝐦𝐞−𝐓𝐚𝐩𝐩𝐞𝐝 𝐕𝐨𝐥𝐮𝐦𝐞
𝐓𝐚𝐩𝐩𝐞𝐝 𝐕𝐨𝐥𝐮𝐦𝐞
 
 
5. Hasusner Ratio: 
The hasusner ratio is an not direct index of ease of 
bleach flow. It was calculated by the following 
formula 
 
𝑯𝒂𝒔𝒖𝒔𝒏𝒆𝒓 𝑹𝒂𝒕𝒊𝒐 =
𝐓𝐚𝐩𝐩𝐞𝐝  𝐃𝐞𝐧𝐬𝐢𝐭𝐲
𝐁𝐮𝐥𝐤  𝐃𝐞𝐧𝐬𝐢𝐭𝐲
 
 
B) Evaluation study of Immedeate release dosage 
form: (1, 3, 4, 17) 
                      
A. 
1. Appearance: 
The common explanation of formulation is its visual 
identity and all above elegance, textures, color, 
shape, and surface. These all parameters are essential 
for consumer acceptance. 
But they some environmental factor are affect such as 
temperature, storage area, manufacturing process etc. 
 
2. Weight variation: 
The weight variation test is establish twenty tablets or 
capsules was selected to the random from each 
formulation and  weighed separately to check for 
weight variation.  Some factor are affected to the 
weight variation such as manufacturing process, 
hardness of tablets, preparation  process of granules, 
used in low amount of binding agent. 
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3. Friability: 
Friability is the loss of weight of tablet in the 
container due to remove of fine material from the 
surface. Friability test is carried out to access the 
capacity of the tablet or to withstand abrasion in 
packaging, handling and moving. Roche friabilator 
was used working for finding the friability of the 
tablets. They 20 tablets for the same formulation 
were weighed and these tablets are taken in Roche 
friabilator   that rotated at 25 rpm for 4 minutes. The 
tablets were degusted and weighed of these tablets 
are again. The percentage of weight defeat was 
calculated again. The amount of weight defeat was 
calculated using the formula. 
 
𝑭𝒓𝒊𝒂𝒃𝒊𝒍𝒊𝒕𝒚 =
𝐖 𝐢𝐧𝐢𝐭𝐢𝐚𝐥−𝐖 𝐟𝐢𝐧𝐚𝐥
𝐖 𝐟𝐢𝐧𝐚𝐥
× 100 
 
4. Thickness:                                                                                                                                            
The thickness of the tablets was determined by the 
use of venire calipers. 10 tablets are randomly choose 
were used for function of thickness that expressed in 
Mean± SD and unit is mm. 
The some factor are affecting the thickness of tablet 
is diameter of punch, granules size etc. 
 
5. Hardness: 
The hardness of the tablet is an sign of its power 
against struggle of tablets to capping, abrasion or 
breakage under storage condition, handling and 
transportation before usage Selected 10 tablets from 
pooled sample and measured the hardness of tablet 
using calibrated hardness tester like Monsanto 
hardness tester. Hardness measured in kg/cm. The 
some factor is affect in the hardness of tablet such as 
machine speed, binding agent, diameter of die, etc.  
 
6. Disintegration: 
Disintegration test of the tablet was performed on the 
6 tablets. Placed one tablet in each of the six tubes of 
the basket, added the disc to each tube and manage 
the apparatus using water at 37 ± 2˚C as the 
concentrated fluid. At the end of 30 minutes, pick up 
the basket from the fluid and observed the tablets. All 
the tablets should disintegrate. Recorded the 
disintegration time in minute and seconds.  
  
7. Wetting Time: 
 The wetting time of tablets was measured using a 
easy procedure. Five round tissue papers of 10cm 
width they located in a Petri dish containing 0.2% 
w/v solution of amaranth (10ml). One tablet was 
watchfully located on the surface of the tissue paper. 
The sometime required for develop the blue color due 
to amaranth water-soluble dye on the upper surface of 
the tablets was noted as the wetting time. 
 
9.  In- vitro Dissolution Profile: 
Immediate release formulation are subjected to the in 
vitro drug release study in the  pH 6.8 phosphate 
buffer or 0.1N HCl for 30 minutes times to access the 
capability of the formulation for provide immediate 
drug delivery. Drug release studies are carried out in 
dissolution test apparatus using specific volume 
900ml of dissolution media maintain at 37±0.2˚C. 
The tablets or capsule are set aside in the cylindrical 
basket placed in medium with paddle then rotate at 
100 rpm. 5ml of the sample from the dissolution 
medium are remote at each time interval (5, 10, 15 & 
30 minutes) and 5ml of fresh or new medium was 
replaced each time. The samples were filtered and 
from the filtrate 1ml was taken and then diluted to the 
10ml. These samples were analyzed by 
spectrophotometrically and further calculation was 
carried out to get drug release. The drug released 
information were plotted and tested with zero order, 
First order. The dissolution kinetic parameters, 
dissolution rate constants, correlation coefficient and 
dissolution effectiveness were calculated. 
 
B. Capsule:(24) 
1. Appearance: - The appearance as same as the 
evaluation of tablet. 
2. Weight variation: - The weight variation test as 
same as the evaluation of tablet. 
3. Lock Length: - Ten individual capsules are taken 
from formulation trial batch and lock length is 
measured using by hand using verniear caliper and 
average of 10 capsules was noted.  
4. In vitro Dissolution: - The In vitro Dissolution 
study as same as the evaluation of tablet. 
5.  Disintegration: - The disintegration study of 
capsule study as same as the evaluation of tablet. 
6. Content Uniformity: - Ten capsules were weighed 
and their contents were removed. An accurately 
weighed sample equivalent to 100mg of drug was 
taken in a volumetric flask (100ml). The content was 
dissolved in 0.1N HCL and volume made up to 
100ml. This solution was filtered through Watt man 
filter paper No.41 The solution was diluted and the 
absorbance was measured. The drug content was 
measured. 
 
C. Pellets: - (21,22) 
1. Appearance: - The appearance of pellets as same 
as above tablet and capsule formulation. 
2. Particle Size: - The size distribution of the 
manufacturing by pellets was investigate using laser 
light diffraction (Mastersizer Scirocco 2000, Malvern 
Instruments, Grove wood Road, UK). For a typical 
experiment, about pellets was fed into the sample 
micro feeder. All samples were analyzed five times 
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and average results were taken. The sizes below 
which 10% d(0.1)),  (d(0.5)) and  (d(0.9)) of the 
pellets were present were used to characterize the 
pellet size distribution. The mean diameter was taken 
as the average of d(0.1), d(0.5) and d(0.9) values.  
3. Drug Content: - Drug content of the 
manufactured pellets was determined by the 
spectrophotometrically. Pellets were crushed in a 
porcelain mortar and about 25mg of crushed pellets 
was dispensed in a 20ml of distilled water under the 
sonication for 5min. The supernatant was filtered and 
measured spectrophotometrically. The drug content 
was calculate using a pre-constructed calibration 
curve. 
4. In- vitro Dissolution: - in vitro dissolution study 
of pellets same as above as evaluation of tablet and 
capsule formulation. 
 
CONCLUSION:  
There is a clear chance for new improved oral 
products arising within this market segment. 
Approximately one-third of patients are require fast 
therapeutic action of drug, resultant in poor 
compliance with conventional drug therapy which 
leads to reduced overall therapy effectiveness. A new 
dosage format, the immediate release pharmaceutical 
formulation has been developed which offers the 
shared advantages of ease of dosing and convenience 
of dosing. These formulations are designed to 
discharge the medicaments with an better rate. Due to 
the constraints of the current technologies as tinted 
above, there is an unmet need for improved 
manufacturing processes for immediate release 
pharmaceutical form that are automatically strong, 
allowing ease of packaging, handling and with the 
manufacturing costs same to that of conventional 
tablets or capsules. 
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